Matthew Shinkle

The FDA approved ensartinib for the treatment of certain patients with ALK-positive locally advanced or metastatic non-small cell lung cancer.The indication applies to use of the agent for adults not previously prescribed an ALK inhibitor.

SAN DIEGO — Tabelecleucel provided durable benefit to solid organ or allogeneic hematopoietic cell transplant recipients with Epstein-Barr virus-driven post-transplant lymphoproliferative disease, according to study results.

The FDA granted an encorafenib-led combination accelerated approval for the treatment of certain patients with metastatic colorectal cancer.

The role of AI in oncology and hematology expanded dramatically in 2024. Research continues to support its expanded use in diagnosis, staging and treatment decision-making.

There are more than 18 million cancer survivors in the United States, according to American Cancer Society.

Key takeaways: Women with ovarian cancer who received palliative care earlier than 3 months before death had less aggressive end-of-life care.

Regular physical activity prior to a cancer diagnosis lowered a patient's risk for disease progression and death, according to study findings.

Key takeaways: Researchers observed responses at all dose levels, with the recommended phase 2 regimen linked to durable response.

SAN ANTONIO — The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response for certain patients with triple-negative breast cancer.

SAN DIEGO — Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings achieved worse survival outcomes than those who received the agents in pivotal trials.